Literature DB >> 16732030

Comparison of the glycemic effects of rosiglitazone and pioglitazone in triple oral therapy in type 2 diabetes.

Michael T Tran1, Maria D Navar, Mayer B Davidson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2006        PMID： 16732030     DOI： 10.2337/dc06-0494

Source DB:  PubMed          Journal:  Diabetes Care        ISSN： 0149-5992            Impact factor:   19.112


× No keyword cloud information.
  7 in total

1.  [Recommendations for the pharmacological treatment of hyperglycemia in type 2 diabetes].

Authors:  Edelmiro Menéndez Torre; Francisco Javier Lafita Tejedor; Sara Artola Menéndez; Jesús Millán Núñez-Cortés; Angeles Alonso García; Manuel Puig Domingo; José Ramón García Solans; Fernando Alvarez Guisasola; Javier García Alegría; Javier Mediavilla Bravo; Carlos Miranda Fernández-Santos; Ramón Romero González
Journal:  Aten Primaria       Date:  2011-03-05       Impact factor: 1.137

2.  Sitagliptin compared with thiazolidinediones as a third-line oral antihyperglycemic agent in type 2 diabetes mellitus.

Authors:  Stanley H Hsia; Maria D Navar; Petra Duran; Magda Shaheen; Mayer B Davidson
Journal:  Endocr Pract       Date:  2011 Sep-Oct       Impact factor: 3.443

Review 3.  Efficacy and tolerability of pioglitazone in patients with type 2 diabetes mellitus: comparison with other oral antihyperglycaemic agents.

Authors:  Giuseppe Derosa
Journal:  Drugs       Date:  2010-10-22       Impact factor: 9.546

4.  Insulin glargine compared to NPH among insulin-naïve, U.S. inner city, ethnic minority type 2 diabetic patients.

Authors:  Stanley H Hsia
Journal:  Diabetes Res Clin Pract       Date:  2010-12-13       Impact factor: 5.602

Review 5.  Pro's and con's of the early use of insulin in the management of type 2 diabetes: a clinical evaluation.

Authors:  Mayer B Davidson
Journal:  Curr Opin Endocrinol Diabetes Obes       Date:  2009-04       Impact factor: 3.243

6.  Hidden complexities in assessment of glycemic outcomes: are quality rankings aligned with treatment?

Authors:  Leonard M Pogach; Mangala Rajan; Miriam Maney; Chin-Lin Tseng; David C Aron
Journal:  Diabetes Care       Date:  2010-07-09       Impact factor: 19.112

Review 7.  A review of pioglitazone HCL and glimepiride in the treatment of type 2 diabetes.

Authors:  Mozhgan Dorkhan; Anders Frid
Journal:  Vasc Health Risk Manag       Date:  2007
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.